V. Amodio

CD4 T cell dependent rejection of beta 2 microglobulin null mismatch repair deficient tumors.

A. Bardelli, F. Di Nicolantonio, A. Mondino, 2021, Cancer discovery.

Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment Features.

A. Bardelli, A. Sapino, S. Marsoni, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance

A. Bardelli, S. Marsoni, F. Di Nicolantonio, 2022, Cancer cell.

Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers

A. Bardelli, A. Sartore-Bianchi, S. Siena, 2021, Cancers.

Adaptive mutability of colorectal cancers in response to targeted therapies

A. Bardelli, L. Trusolino, A. Bertotti, 2019, Science.

Evolving neoantigen profiles in colorectal cancers with DNA repair defects

A. Bardelli, C. Isella, L. Trusolino, 2019, Genome Medicine.

EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal cancer.

N. Rosen, A. Bardelli, Y. Murciano-Goroff, 2020, Cancer discovery.

High-dose vitamin C enhances cancer immunotherapy

Massimo Zucchetti, Francesco Sassi, Sergio Abrignani, 2020, Science Translational Medicine.

T Cells Expressing Receptor Recombination/Revision Machinery Are Detected in the Tumor Microenvironment and Expanded in Genomically Over-unstable Models

A. Bardelli, M. Colombo, G. Pruneri, 2021, Cancer Immunology Research.

DNA repair-dependent immunogenic liabilities in colorectal cancer: opportunities from errors.

V. Amodio, A. Bardelli, P. P. Vitiello, 2024, British journal of cancer.